HuMAB companies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HuMAB companies

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: nigel bates	4/14/2015 4:14:55 AM
	of 1022

From the ABLX annual report: annual report (p18) (expected) Regulatory events... 2015 ALX-0761, PIb psoriasis (Merck Serono) 2016 ALX-0171, PIIa infant RSV (wholly owned) ALX-0061, PIIb combo, and PIIb monotherapy RA (AbbVie) 2017 Caplacizumab, PIII TTP (wholly owned) ALX-0171, PIIb infant RSV (wholly owned) ALX-0761, PIIa psoriasis (Merck Serono) ALX-0141 (RANKL) & Ozoralizumab (TNFalpha), PI/II in China (Eddingpharm)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next